Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research
暂无分享,去创建一个
M. Horowitz | M. Bishop | Carole B. Miller | P. McCarthy | A. Keating | H. Lazarus | D. Weisdorf | B. Logan | B. Bolwell | M. Litzow | S. Giralt | D. Marks | P. Wiernik | D. Weisdorf | J. Cahn | J. Sierra | F. Loberiza | G. Milone | P. Wiernik | J. Russell | M. Bishop | M. Litzow | H. Lazarus | S. Giralt | B. Bolwell | J. Sierra | M. Horowitz | A. Keating | S. Gandham | B. Logan | F. Loberiza | C. Miller | J. Russell | G Milone | P H Wiernik | S Gandham | B J Bolwell | F R Loberiza
[1] R. Wells. Induction therapy for adults with acute lymphoblastic leukemia , 2006, Current oncology reports.
[2] F. Aversa,et al. Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options , 2006, Bone Marrow Transplantation.
[3] J. Klein,et al. Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research , 2006, British journal of haematology.
[4] H. Dombret,et al. Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials , 2006, Leukemia.
[5] G. Cho,et al. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia , 2005, Bone Marrow Transplantation.
[6] K. Cornetta,et al. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] M. Béné,et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. , 2004, Blood.
[8] H. Dombret,et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Harriet Noreen,et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. , 2004, Blood.
[10] V. Diehl,et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] S. Heimfeld,et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. , 2003, Blood.
[12] S. Singhal,et al. The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia. , 2002, Blood.
[13] Todd E DeFor,et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[14] J. Klein,et al. Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] C. Craddock,et al. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. , 2002, Blood.
[16] J. Hansen,et al. Trends in transplantation of hematopoietic stem cells from unrelated donors. , 2001, Current opinion in hematology.
[17] B. Löwenberg,et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. , 2001, Blood.
[18] D. Monos,et al. Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology. , 2001, Tissue antigens.
[19] R. Larson. Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B. , 2000, Hematology/oncology clinics of North America.
[20] Terry L. Smith,et al. Primary refractory and relapsed adult acute lymphoblastic leukemia , 1999, Cancer.
[21] M. Horowitz,et al. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission. , 1998, Leukemia research.
[22] M. Tanimoto,et al. Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission , 1998, Bone Marrow Transplantation.
[23] S. Sallan,et al. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. , 1997, Blood.
[24] F. Mandelli,et al. Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R‐87 protocol , 1997, British journal of haematology.
[25] M. Labopin,et al. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis , 1997, Bone Marrow Transplantation.
[26] H. Lazarus,et al. Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from The Eastern Cooperative Oncology Group (ECOG) , 1997, Bone Marrow Transplantation.
[27] E. Thiel,et al. Long-Term Follow-up of Adults with Acute Lymphoblastic Leukemia in First Remission Treated with Chemotherapy or Bone Marrow Transplantation , 1995, Annals of Internal Medicine.
[28] S. Feig,et al. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors , 1994, British journal of haematology.
[29] F. Appelbaum,et al. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. , 1994, Blood.
[30] W. Woods,et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome , 1994, British journal of haematology.
[31] S. Piantadosi,et al. Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] J. Hernández-Rivas,et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. , 2005, Haematologica.
[33] M. Vignetti,et al. GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia. , 2004, Haematologica.
[34] J. Sierra,et al. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. , 2003, Haematologica.
[35] K. Sepkowitz,et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. , 2001, Hematology. American Society of Hematology. Education Program.
[36] D. Confer,et al. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation. , 1999, Clinical transplants.
[37] A. Nademanee,et al. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. , 1991, Blood.
[38] H. Prentice,et al. Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia. , 1989, Leukemia.